Scope Of Riegel V. Medtronic Is Narrow: Experts

Law360, New York (February 21, 2008, 12:00 AM EST) -- After taking a closer look at the U.S. Supreme Court’s ruling in Riegel v. Medtronic, product liability lawyers are saying the decision is not as big of a victory for medical device makers as reported and is only going to preempt a small group of lawsuits.

In step with the majority of appeals court decisions, the Supreme Court determined 8-1 on Wednesday that companies whose medical devices have undergone a rigorous review process by the U.S. Food and Drug Administration cannot be sued under state law...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.